Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Status:
Enrolling by invitation
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the long term safety and efficacy of AT-1501 (tegoprubart) compared
with tacrolimus in patients undergoing kidney transplantation.